77 related articles for article (PubMed ID: 18573730)
1. Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream.
Ehst BD; Dréno B; Vonderheid EC
Eur J Dermatol; 2008; 18(4):467-8. PubMed ID: 18573730
[No Abstract] [Full Text] [Related]
2. Long-term remission of primary cutaneous neutrophil-rich CD30+ anaplastic large cell lymphoma treated with topical imiquimod. A case report.
Calista D; Riccioni L; Bagli L; Valenzano F
J Eur Acad Dermatol Venereol; 2016 May; 30(5):899-901. PubMed ID: 25809386
[No Abstract] [Full Text] [Related]
3. Primary cutaneous CD30-positive anaplastic large cell lymphoma in a 16-year-old girl.
Kocabaş E; Türel Ermertcan A; Akinci S; Temiz P; Gündüz K
Int J Dermatol; 2012 Nov; 51(11):1353-8. PubMed ID: 21972869
[No Abstract] [Full Text] [Related]
4. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
Didona B; Benucci R; Amerio P; Canzona F; Rienzo O; Cavalieri R
Br J Dermatol; 2004 Jun; 150(6):1198-201. PubMed ID: 15214911
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
[No Abstract] [Full Text] [Related]
6. Anaplastic large-cell T-cell lymphoma.
Stein JA; Soldano AC; Latkowski JA
Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
[TBL] [Abstract][Full Text] [Related]
7. Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical Imiquimod.
Kubicki SL; Park KE; Aung PP; Duvic M
J Drugs Dermatol; 2019 May; 18(5):460-462. PubMed ID: 31141854
[TBL] [Abstract][Full Text] [Related]
8. Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox.
Dao H; Barr PM; Honda K
J Am Acad Dermatol; 2011 Jun; 64(6):e123-5. PubMed ID: 21571160
[No Abstract] [Full Text] [Related]
9. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
Coors EA; Schuler G; Von Den Driesch P
Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
[TBL] [Abstract][Full Text] [Related]
11. RF - Brentuximab as Treatment for CD30
Morgado-Carrasco D; Combalia A; Estrach Panella T
Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):769-770. PubMed ID: 31151669
[No Abstract] [Full Text] [Related]
12. Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
Lee JH; Cheng AL; Lin CW; Kuo SH
Br J Dermatol; 2009 Apr; 160(4):887-9. PubMed ID: 19222454
[No Abstract] [Full Text] [Related]
13. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
Papalas JA; Van Mater D; Wang E
Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
[TBL] [Abstract][Full Text] [Related]
14. Relapse Pattern and Treatment Outcome of Curative Radiotherapy for Primary Cutaneous CD30+ Anaplastic Large-cell Lymphoma: A Retrospective Cohort Study.
Huang BS; Chen WY; Wang CW; Cheng AL; Hong JH; Kuo SH
Acta Derm Venereol; 2016 Mar; 96(3):394-5. PubMed ID: 26463467
[No Abstract] [Full Text] [Related]
15. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
Kong YY; Dai B; Kong JC; Lu HF; Shi DR
Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
[TBL] [Abstract][Full Text] [Related]
16. Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin.
Desai A; Telang GH; Olszewski AJ
Ann Hematol; 2013 Apr; 92(4):567-8. PubMed ID: 23086510
[No Abstract] [Full Text] [Related]
17. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME
Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
[TBL] [Abstract][Full Text] [Related]
18. Practical Management of CD30⁺ Lymphoproliferative Disorders.
Hughey LC
Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
[TBL] [Abstract][Full Text] [Related]
19. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
Ferrara G; Ena L; Cota C; Cerroni L
Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
[TBL] [Abstract][Full Text] [Related]
20. Congenital primary cutaneous anaplastic large-cell lymphoma: a case report.
Seo AN; Lee SJ; Choi YH; Chung HY; Huh J; Yoon GS
Am J Dermatopathol; 2015 May; 37(5):398-400. PubMed ID: 25365497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
